+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Galectin Therapeutics Inc (GALT) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company's products comprise GR-MD-02 and GM-CT-01. Its GR-MD-02 is a drug candidate used for treating fibrotic liver disease. Its GM-CT-01 is a vaccine used to treat patients with advanced melanoma, a deadly skin cancer. Galectin Therapeutics offers research and study of science of galectin proteins. The company's products are used to treat fibrosis, galectin effects on liver fibrosis, lung fibrosis and others. Galectin Therapeutics is headquartered in Norcross, Georgia, the US.

Galectin Therapeutics Inc Key Recent Developments

Nov 07, 2017: Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update
Sep 25, 2017: Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Conference for NASH Summit Europe 2017
Sep 18, 2017: Galectin Therapeutics: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Aug 18, 2017: Clarification: Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update
Aug 14, 2017: Galectin Therapeutics Reports 2017 Second Quarter Financial Results and Provides Business Update

This comprehensive SWOT profile of Galectin Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Galectin Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Galectin Therapeutics Inc - Key Information
  • Galectin Therapeutics Inc - Overview
  • Galectin Therapeutics Inc - Key Employees
  • Galectin Therapeutics Inc - Key Employee Biographies
  • Galectin Therapeutics Inc - Key Operational Heads
  • Galectin Therapeutics Inc - Major Products and Services
  • Galectin Therapeutics Inc - History
  • Galectin Therapeutics Inc - Company Statement
  • Galectin Therapeutics Inc - Locations And Subsidiaries
  • Galectin Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Galectin Therapeutics Inc - Business Description
  • Galectin Therapeutics Inc - Corporate Strategy
  • Galectin Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Galectin Therapeutics Inc - Strengths
  • Galectin Therapeutics Inc - Weaknesses
  • Galectin Therapeutics Inc - Opportunities
  • Galectin Therapeutics Inc - Threats
  • Galectin Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Galectin Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Galectin Therapeutics Inc, Key Information
  • Galectin Therapeutics Inc, Key Ratios
  • Galectin Therapeutics Inc, Share Data
  • Galectin Therapeutics Inc, Major Products and Services
  • Galectin Therapeutics Inc, History
  • Galectin Therapeutics Inc, Key Employees
  • Galectin Therapeutics Inc, Key Employee Biographies
  • Galectin Therapeutics Inc, Key Operational Heads
  • Galectin Therapeutics Inc, Other Locations
  • Galectin Therapeutics Inc, Subsidiaries
  • Galectin Therapeutics Inc, Key Manufacturing facilities
  • Galectin Therapeutics Inc, Key Competitors
  • Galectin Therapeutics Inc, SWOT Analysis
  • Galectin Therapeutics Inc, Ratios based on current share price
  • Galectin Therapeutics Inc, Annual Ratios
  • Galectin Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Galectin Therapeutics Inc, Performance Chart
  • Galectin Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown